Synthesis 2022; 54(17): 3874-3882
DOI: 10.1055/s-0040-1719885
special topic
Special Issue in memory of Prof. Ferenc Fülöp

Towards Tianeptine Analogues: Synthesis of New Ring Systems Containing a Dibenzo[c,f][1,2]thiazepine S,S-Dioxide Core

Gábor Berecz
a   Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary
,
András Dancsó
a   Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary
,
Dóra R. Németh
a   Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary
,
b   Institute of Organic Chemistry, Research Centre for Natural Sciences, Magyar tudósok krt. 2, 1117 Budapest, Hungary
,
a   Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary
,
Balázs Volk
a   Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary
› Author Affiliations


Dedicated to the memory of the late Professor Ferenc Fülöp (1952–2021)

Abstract

In the course of the synthesis of fused-ring analogues of the antidepressant drug tianeptine, representatives of three new heterocyclic ring systems, indolo[1,7-bc][1,2]benzothiazepines (and their 4,5-dihydro analogues), 5,6-dihydroquino[1,8-bc][1,2]benzothiazepines, and [1,2]benzothiazepino[4,3,2-jk]carbazoles, as well as their intermediates, have been prepared. The tetracyclic and pentacyclic ring systems containing either an oxo or a hydroxy functional group are suitable for introducing various side chains, including potential pharmacophores. For this latter transformation, examples are demonstrated by conversion of the hydroxy group into a chloro moiety and subsequent reaction with amines or with primary alcohols bearing a tertiary amino side chain. Two fused-ring derivatives exhibiting the side-chain characteristics of tianeptine have also been synthesized. Altogether 40 compounds are described in the present manuscript, eight of them are also characterized by single-crystal X-ray diffraction.

Supporting Information



Publication History

Received: 15 October 2021

Accepted: 17 December 2021

Article published online:
07 February 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Malen C, Poignant J.-C, Danrée B. French Pat. Appl FR 2104728, 1969
  • 2 Kato G, Weitsch AF. Clin. Neuropharmacol. 1988; 11 Suppl. 2 S43-S50
  • 3 Gassaway MM, Rives M.-L, Kruegel AC, Javitch JA, Sames D. Transl. Psychiatry 2014; 4: e411 ; Chem. Abstr. 2014, 161, 710561
  • 4 Berridge KC, Kringelbach ML. Psychopharmacology 2008; 199: 457
  • 5 El Zahran T, Schier J, Glidden E, Kieszak S, Law R, Bottei E, Aaron C, King A, Chang A. MMWR. Morbidity and Mortality Weekly Report 2018; 67: 815
  • 6 Kruegel AC. PhD Thesis . Columbia University; USA: 2015
  • 7 Grislain L, Gele P, Bertrand M, Luijten W, Bromet N, Salvadori C, Kamoun A. Drug Metab. Dispos. 1990; 18: 804
  • 8 Horlachuk N, Halkevych I, Logoyda L, Mosula L, Zarivna N, Polyauk O. Int. J. Green Pharm. 2019; 13: 87
  • 9 Stablon® (tianeptine), summary of product characteristics (accessed Jan 24, 2022): http://mri.cts-mrp.eu/download/PT_H_0453_001_FinalSPC.pdf
  • 10 https://www.tga.gov.au/sites/default/files/final-decision-and-reasons-for-decision-by-delegate-october-2017.pdf , page 160 (accessed Jan 24, 2022)
  • 11 Kruegel AC, Henke A, Gassaway MM, Rivers M.-L, Javitch JA, Sames D. PCT Intern. Pat. Appl WO 2015138791, 2015 ; Chem. Abstr. 2015, 163, 442907.
  • 12 Kruegel A, Sames D, Gassaway M, Javitch JA. PCT Intern. Pat. Appl WO 2017049158, ; Chem. Abstr. 2017, 166, 350486
  • 13 Kruegel A, Sames D, Javitch JA. PCT Intern. Pat. Appl WO 2018170275, Chem. Abstr. 2018, 169, 389015.
  • 14 Laconde G, Depreux P, Berthelot P, Pommery N, Hénichart J.-P. Eur. J. Med. Chem. 2005; 40: 167
  • 15 Laconde G, Depreux P, Berthelot P, Hénichart J.-P. Heteroat. Chem. 2005; 16: 39
  • 16 Catsoulacos P, Pelecanou M, Camoutsis C. J. Heterocycl. Chem. 1991; 28: 1437
  • 17 Shirai H, Hayazaki T, Maki A. Yakugaku Zasshi 1971; 91: 1228 ; Chem. Abstr. 1972, 76, 34228
  • 18 Gardner DV. Eur. Pat EP 55546, 1982 ; Chem. Abstr. 1982, 97, 198228.
  • 19 Catsoulacos P. Bull. Soc. Chim. Fr. 1973; 6: 2136
  • 20 Gardner DV, White TJ. Eur. Pat EP 90552, 1984 ; Chem. Abstr. 1984, 100, 139160.
  • 21 Hovius K, Wagenaar A, Engberts JB. F. N. Tetrahedron Lett. 1983; 24: 3137
    • 22a Kong W, Merino E, Nevado C. Angew. Chem. Int. Ed. 2014; 53: 5078
    • 22b Waser J, Gaspar B, Nambu H, Carreira EM. J. Am. Chem. Soc. 2006; 128: 11693
  • 23 Lehmann F, Haile S, Axen E, Medina C, Uppenberg J, Svensson S, Lundbäck T, Rondahl L, Barf T. Bioorg. Med. Chem. Lett. 2004; 14: 4445
  • 24 Duddeck H, Dietrich W, Tóth G. Structure Elucidation by Modern NMR . Springer-Steinkopff; Darmstadt: 1998
  • 25 Pretsch E, Tóth G, Munk ME, Badertscher M. Computer-Aided Structure Elucidation. Spectra Interpretation and Structure Generation. Wiley-VCH; Weinheim: 2002
  • 26 Vogel’s Textbook of Practical Organic Chemistry, 5th ed. Furniss BS, Hannaford AJ, Smith PW. G, Tatchell AR. Longman; Harlow: 1989: 220-221